Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bross

Showing results (471-480 of 779) with videos related to

Pageof 78
Sort By:
Human Genetics|April 1, 1991
Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coliN Gregersen, B S Andresen, P Bross, et al.
Immunitat Und Infektion|April 1, 1985
[In vitro and in vivo studies with interleukin 2 (IL-2) and various immunostimulants in a patient with AIDS]P Vaith, D Maas, D Feigl, et al.
Biochemical Medicine and Metabolic Biology|June 1, 1994
Characterization of wild-type human medium-chain acyl-CoA dehydrogenase (MCAD) and mutant enzymes present in MCAD-deficient patients by two-dimensional gel electrophoresis: evidence for post-translational modification of the enzymeP Bross, T G Jensen, B S Andresen, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Chemical Society Reviews|November 29, 2024
Unifying thermochemistry concepts in computational heterogeneous catalysisBjarne Kreitz, Gabriel S Gusmão, Dingqi Nai, et al.
Acta Haematologica|January 1, 1978
Bone marrow transplantation between mixed leukocyte culture reactive siblingsK G Blume, K J Bross, R K Chillar, et al.
Der Urologe. Ausg. A|October 22, 2003
[Sacral neuromodulation in treatment of functional disorders of the lower urinary tract. An overview of basic principles, indications, outcomes]A Bannowsky, C Seif, S Sugimoto, et al.
Journal of Inherited Metabolic Disease|January 11, 2012
Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allelePeter Bross, Jane B Frederiksen, Anne S Bie, et al.
Cell Stress & Chaperones|April 16, 2010
Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in miceJane H Christensen, Marit N Nielsen, Jakob Hansen, et al.
Pageof 78

Showing results (471-480 of 779) with videos related to

Sort By:
Pageof 78
Human Genetics|April 1, 1991
Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coliN Gregersen, B S Andresen, P Bross, et al.
Immunitat Und Infektion|April 1, 1985
[In vitro and in vivo studies with interleukin 2 (IL-2) and various immunostimulants in a patient with AIDS]P Vaith, D Maas, D Feigl, et al.
Biochemical Medicine and Metabolic Biology|June 1, 1994
Characterization of wild-type human medium-chain acyl-CoA dehydrogenase (MCAD) and mutant enzymes present in MCAD-deficient patients by two-dimensional gel electrophoresis: evidence for post-translational modification of the enzymeP Bross, T G Jensen, B S Andresen, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Chemical Society Reviews|November 29, 2024
Unifying thermochemistry concepts in computational heterogeneous catalysisBjarne Kreitz, Gabriel S Gusmão, Dingqi Nai, et al.
Acta Haematologica|January 1, 1978
Bone marrow transplantation between mixed leukocyte culture reactive siblingsK G Blume, K J Bross, R K Chillar, et al.
Der Urologe. Ausg. A|October 22, 2003
[Sacral neuromodulation in treatment of functional disorders of the lower urinary tract. An overview of basic principles, indications, outcomes]A Bannowsky, C Seif, S Sugimoto, et al.
Journal of Inherited Metabolic Disease|January 11, 2012
Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allelePeter Bross, Jane B Frederiksen, Anne S Bie, et al.
Cell Stress & Chaperones|April 16, 2010
Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in miceJane H Christensen, Marit N Nielsen, Jakob Hansen, et al.
Pageof 78